Dan ArinSilasiMD

PubMed

• Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
  Dana M Roque, Eric R Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E Schwartz, Gautam G ...> ;British Journal of Cancer. 2024 Apr 1
• 1 citations
  A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...
  Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Craft...> ;International Journal of Gynecological Cancer. 2023 Sep 4
• 2 citations
  Minimally Invasive Ovarian-Preserving Approach for the Management of a Sclerosing Stromal Tumor in an Adolescent: A Case Report.
  Chaarushi Ahuja, Joan Tymon-Rosario, Douglas Rottmann, Rita Abi Raad, Dan-Arin Silasi, Alla Vash-Margita> ;Journal of Pediatric and Adolescent Gynecology. 2022 Aug 1
• 3 citations
  Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
  Dana M Roque, Eric R Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E Schwartz, Gautam G ...> ;British Journal of Cancer. 2022 Jun 1
• 28 citations
  A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
  Stefania Bellone, Dana M Roque, Eric R Siegel, Natalia Buza, Pei Hui, Elena Bonazzoli, Adele Guglielmi, Luca Zammataro, Nupur Nagarkatti, Samir Zaidi, Jungsoo Lee, Dan...> ;Cancer. 2022 Mar 15
• 8 citations
  DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.
  Joan Tymon-Rosario, Elena Bonazzoli, Stefania Bellone, Aranzazu Manzano, Silvia Pelligra, Adele Guglielmi, Barbara Gnutti, Nupur Nagarkatti, Burak Zeybek, Paola Manara...> ;Gynecologic Oncology. 2021 Nov 1
• 45 citations
  Integrated mutational landscape analysis of uterine leiomyosarcomas
  Jungmin Choi, Aranzazu Manzano, Weilai Dong, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Xiaotong Yao, Aditya Deshpande, Samir Zaidi, Adele Guglielmi, Barbara G...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Apr 13
• 1 citations
  Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer.
  Christopher Walker, Tuan-Minh Nguyen, Shlomit Jessel, Ayesha B. Alvero, Dan-Arin Silasi, Thomas J. Rutherford, Sorin Draghici, Gil Mor> ;Cancers. 2021 Jan 17
• 9 citations
  Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study.
  Emily Webster, Ghanshyam Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher Ke Arkfeld, Vaagn Andikyan, G...> ;Gynecologic Oncology Reports. 2020 Nov 2
• 112 citations
  Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas ...
  Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko K. Chambers, Angeles Alvarez Secord, Laura J. Havrilesky, David M. O'M...> ;Clinical Cancer Research. 2020 Aug 1
• 2 citations
  Laparoscopic Posterior Versus Lateral Transversus Abdominis Plane Block in Gynecology.
  Kelly Benabou, S Kim, Christina H Tierney, Joel E Messom, Tassos C. Kyriakides, Shabnam Kashani, Dan-Arin Silasi, Masoud Azodi, F. Seifi> ;JSLS. 2020 Jul 1
• 2 citations
  Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
  Elena Bonazzoli, Stefania Bellone, Luca Zammataro, Barbara Gnutti, Adele Guglielmi, Silvia Pelligra, Nupur Nagarkatti, Paola Manara, Joan Tymon-Rosario, Burak Zeybek, ...> ;Gynecologic Oncology. 2020 Jun 26
• 17 citations
  Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial aden...
  Emanuele Perrone, Paola Manara, Salvatore Lopez, Stefania Bellone, Elena Bonazzoli, Aranzazu Manzano, Luca Zammataro, Anna Bianchi, Burak Zeybek, Natalia Buza, Joan Ty...> ;Molecular Oncology. 2020 Mar 1
• 26 citations
  Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irin...
  Emanuele Perrone, Salvatore Lopez, Burak Zeybek, Stefania Bellone, Elena Bonazzoli, Silvia Pelligra, Luca Zammataro, Aranzazu Manzano, Paola Manara, Anna Bianchi, Nata...> ;Frontiers in Oncology. 2020 Feb 12
• 26 citations
  Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas.
  Salvatore Lopez, Emanuele Perrone, Stefania Bellone, Elena Bonazzoli, Burak Zeybek, Chanhee Han, Joan Tymon-Rosario, Gary Altwerger, Gulden Menderes, Anna Bianchi, Luc...> ;Oncotarget. 2020 Feb 4
• 15 citations
  In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.
  Chanhee Han, Emanuele Perrone, Burak Zeybek, Stefania Bellone, Joan Tymon-Rosario, Gary Altwerger, Gulden Menderes, Jacqueline Feinberg, Kaitlin Haines, Mariana Espina...> ;Gynecologic Oncology. 2020 Feb 1
• 22 citations
  Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan.
  Burak Zeybek, Aranzazu Manzano, Anna Bianchi, Elena Bonazzoli, Stefania Bellone, Natalia Buza, Pei Hui, Salvatore Lopez, Emanuele Perrone, Paola Manara, Luca Zammataro...> ;Scientific Reports. 2020 Jan 22
• 46 citations
  Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
  Luca Zammataro, Salvatore Lopez, Stefania Bellone, Francesca Pettinella, Elena Bonazzoli, Emanuele Perrone, Siming Zhao, Gulden Menderes, Gary Altwerger, Chanhee Han, ...> ;Proceedings of the National Academy of Sciences of the United States of America. 2019 Nov 5
• 22 citations
  PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib
  Anna Bianchi, Salvatore Lopez, Gary Altwerger, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Aranzazu Manzano, Paola Manara, Emanuele Perrone, Burak Zeybek, Chanh...> ;Gynecologic Oncology. 2019 Oct 1
• 9 citations
  Challenges of Robotic Gynecologic Surgery in Morbidly Obese Patients and How to Optimize Success.
  Gulden Menderes, Stefan Gysler, Nalini Vadivelu, Dan-Arin Silasi> ;Current Pain and Headache Reports. 2019 Jul 1
• 13 citations
  Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma.
  Uma Deshmukh, Jonathan Black, Javier Perez-Irizarry, Rachel Passarelli, Karen Levy, Amanda Rostkowski, Pei Hui, Thomas J. Rutherford, Alessandro D. Santin, Masoud Azod...> ;Reproductive Sciences. 2019 May 1
• 5 citations
  Pseudovascular Invasion: Minimally Invasive Surgery for Endometrial Cancer.
  F. Seifi, Vinita Parkash, Mitchell Clark, Gulden Menderes, Christina Tierney, Dan-Arin Silasi, Masoud Azodi> ;JSLS. 2019 Apr 1
• 11 citations
  PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.
  Elena Bonazzoli, Emiliano Cocco, Salvatore Lopez, Stefania Bellone, Luca Zammataro, Anna Bianchi, Aranzazu Manzano, Ghanshyam Yadav, Paola Manara, Emanuele Perrone, Ka...> ;Gynecologic Oncology. 2019 Apr 1
• 41 citations
  Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.
  Charles Li, Elena Bonazzoli, Stefania Bellone, Jungmin Choi, Weilai Dong, Gulden Menderes, Gary Altwerger, Chanhee Han, Aranzazu Manzano, Anna Bianchi, Francesca Petti...> ;Proceedings of the National Academy of Sciences of the United States of America. 2019 Jan 8
• 23 citations
  Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes.
  Jacqueline Feinberg, Benjamin B. Albright, Jonathan Black, Lingeng Lu, Rachel Passarelli, Stefan Gysler, Margaret Whicker, Gary Altwerger, Gulden Menderes, Pei Hui, Al...> ;Gynecologic and Obstetric Investigation. 2019 Jan 1
• Join now to see all